Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil

Heart

Volumn 90, Issue 5, 2004, Pages 534-538

  Lindholm, C J A ^b   Fredholm, O ^c   Moller S J ^a   Edvardsson, N ^d   Kronvall, T ^e   Pettersson, T ^f   Firsovaite, V ^b   Roijer, A ^b   Meurling, C J ^b   Platonov, P G ^a,b   Olsson, S B ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c HELSINGBORG HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e Orebro Hospital   (Sweden)

^f CENTRAL HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; VERAPAMIL; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIRECT CURRENT; DISEASE DURATION; DRUG HYPERSENSITIVITY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; MALE; MULTICENTER STUDY; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINUS RHYTHM; SLOW RELEASE FORMULATION; SWEDEN; TREATMENT OUTCOME;

EID: 11144356984     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.017707     Document Type: Article

References (40)

1. Godtfredsen J. Atrial fibrillation: etiology, course and prognosis: a follow-up study of 1212 cases. Copenhagen: Munksgaard, 1975.
2. Kannel W, Abbot R, Savage D, et al. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982;306:1018-22.
3. Petersen P, Godtfredsen J. Atrial fibrillation: a review of course and prognosis. Acta Med Scand 1984;216:5-9.
4. Frick M, Frykman V, Jensen-Urstad M, et al. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients wild persistent atrial fibrillation. Clin Cardiol 2001;24:238-44.
5. Ellenbogen KA, Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J Am Coll Cardiol 1996;28:130-6.
6. Wijffels MC, Kirchhof G, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995;92:1954-68.
7. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation 1996;94:2968-74.
8. Wood MA, Caponi D, Sykes AM, et al. Atrial electrical remodeling by rapid pacing in the isolated rabbit heart: effects of Ca++ and K+ channel blockade. J Inters Card Electrophysiol 1998;2:15-23.
9. Tieleman RG, De Langen C, Van Gelder IC, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-53.
10. Lee S-H, Yu W-C, Cheng J-J, et al. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling. Circulation 2000;101:200-6.
11. Duytschaever M, Mast F, Alessie M. Pro-fibrillatory effects of verapamil in a goat model of atrial fibrillation. Pacing Clin Electrophysiol 1998;21:802.
12. De Simone A, Stabile G, Vitale DF, et al. Pretreatment with verapamil in patients with persistent at chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 1999;34:810-4.
13. Bertaglia E, D'Este D, Zanocco A, et al. Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study. Heart 2001;85:578-80.
14. Tse HF, Wang Q, Yu CM, et al. Effect of verapamil on prevention of atrial fibrillation in patients implanted with an implantable atrial defibrillator. Clin Cardiol 2001;24:503-5.
15. Zardo F, Antonini-Canterin F, Brieda M, et al. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion? Ital Heart J 2001;2:513-8.
16. Van Noord T, Van Gelder IC, Crijns HJ. How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation. J Cardiovasc Electrophysiol 2002;13:822-5.
17. Daoud EG, Knight BP, Weiss R, et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997;96:1542-50.
18. Ramanna H, Elvan A, Hauer R, et al. Verapamil causes increase in dispersion and shortening of refractoriness in human chronic atrial fibrillation. Pacing Clin Electrophysiol 1998;21:802.
19. Inoue M, Inoue D, Omori I, et al. [Electrophysiological effect of verapamil on human atrium]. Kokyu To Junkan 1991;39:891-7.
20. Tieleman RG, Van Gelder IC, Crijns HJ, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31:167-73.
21. Innes G, Vertesi L, Dillon E, et al. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation. Ann Emerg Med 1997;29:126-34.
22. Lamberti F, Pandozi C, Castro A, et al. Prevention of atrial electrical remodelling by pretreatment with Ca antagonists in humans. In: Santini M, ed. Progress in clinical pacing. Armonk: Futura Media Services, 1998:19-24.
23. Anon. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J 2001;22:1852-923.
24. Lau CP, Tse HF. Electrical remodelling of chronic atrial fibrillation. Clin Exp Pharmacol Physiol 1997;24:982-3.
25. Ausma J, Wijffels M, Thone F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-63.
26. Franz MR, Karasik PL, Li C, et al. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997;30:1785-92.
27. Wijffels MC, Kirchhof G, Dorland R, et al. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997;96:3710-20.
28. Daoud EG, Bogun F, Goyal R, et al. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94:1600-6.
29. Meurling CJ, Ingemansson MP, Roijer A, et al. Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil. Europace 1999;1:234-41.
30. Tieleman RG, Gosselink AT, Crijns HJ, et al. Efficacy, safety, and determinants of conversion of atrial fibrillation and flutter with oral amiodarone. Am J Cardiol 1997;79:53-7.
31. Edvardsson N, Olsson SB. Induction of delayed repolarization during chronic beta-receptor blockade. Eur Heart J 1985;6(suppl D):163-9.
32. Anon. Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group. Eur Heart J 1997;18:649-54.
33. Jordaens L, Trouerbach J, Calle P, et al. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. Eur Heart J 1997;18:643-8.
34. Sticherling C, Oral H, Horrocks J, et al. Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness. Circulation 2000;102:2503-8.
35. Van Noord T, Van Gelder IC, Tieleman RG, et al. VERDICT: the verapamil versus digoxin cardioversion trial: a randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2001;12:766-9.
36. Botto GL, Belotti G, Cirò A, et al. Verapamil in prevention of early recurrences of atrial fibrillation: final results of the VERAF study. Eur Heart J 2002;23(suppl):660.
37. De Simone A, Turco P, De Matteis C, et al. Effect of verapamil on secondary cardioversion in patients with early atrial fibrillation recurrence after electrical cardioversion. Am J Cardiol 2002;90:185-7.
38. Shenasa M, Kus T, Fromer M, et al. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol 1988;62:403-7.
39. Rinkenberger RL, Prystowsky EN, Heger JJ, et al. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation 1980;62:996-1010.
40. Daoud EG, Hummel JD, Augostini R, et al. Effect of verapamil on immediate recurrence of atrial fibrillation. J Cardiovasc Electrophysiol 2000;11:1231-7.